Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
40.8M
-
Number of holders
-
211
-
Total 13F shares, excl. options
-
35.3M
-
Shares change
-
+1.11M
-
Total reported value, excl. options
-
$1.21B
-
Value change
-
-$14.8M
-
Put/Call ratio
-
0.1
-
Number of buys
-
114
-
Number of sells
-
-103
-
Price
-
$34.38
Significant Holders of RxSight, Inc. - Common Stock, par value $0.001 per share (RXST) as of Q4 2024
262 filings reported holding RXST - RxSight, Inc. - Common Stock, par value $0.001 per share as of Q4 2024.
RxSight, Inc. - Common Stock, par value $0.001 per share (RXST) has 211 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.3M shares
of 40.8M outstanding shares and own 86.59% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (3.74M shares), BlackRock, Inc. (2.97M shares), VANGUARD GROUP INC (2.38M shares), BANK OF AMERICA CORP /DE/ (2.16M shares), Artisan Partners Limited Partnership (1.55M shares), FMR LLC (1.09M shares), MILLENNIUM MANAGEMENT LLC (1.01M shares), CITADEL ADVISORS LLC (994K shares), STATE STREET CORP (891K shares), and BROWN CAPITAL MANAGEMENT LLC (842K shares).
This table shows the top 211 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.